JP2502318B2 - Whitening cosmetics - Google Patents

Whitening cosmetics

Info

Publication number
JP2502318B2
JP2502318B2 JP19204087A JP19204087A JP2502318B2 JP 2502318 B2 JP2502318 B2 JP 2502318B2 JP 19204087 A JP19204087 A JP 19204087A JP 19204087 A JP19204087 A JP 19204087A JP 2502318 B2 JP2502318 B2 JP 2502318B2
Authority
JP
Japan
Prior art keywords
whitening
tetrahydroxystilbene
cosmetic composition
effect
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP19204087A
Other languages
Japanese (ja)
Other versions
JPS6438009A (en
Inventor
靖規 稲岡
正彦 土屋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pola Chemical Industries Inc
Original Assignee
Pola Chemical Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chemical Industries Inc filed Critical Pola Chemical Industries Inc
Priority to JP19204087A priority Critical patent/JP2502318B2/en
Publication of JPS6438009A publication Critical patent/JPS6438009A/en
Application granted granted Critical
Publication of JP2502318B2 publication Critical patent/JP2502318B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は美白化粧料、更に詳しくはヒドロキシスチル
ベンを有効成分として配合してなる美白化粧料に関す
る。
TECHNICAL FIELD The present invention relates to a whitening cosmetic composition, and more particularly to a whitening cosmetic composition containing hydroxystilbene as an active ingredient.

(従来技術及び発明が解決しようとする問題点) 一般に、日光からの紫外線が皮膚に対して照射される
と、皮膚内のチロジナーゼ活性作用によりメラニンが著
しく生成・増加して皮膚が黒化するとされている。従っ
て、色黒の防止・改善にはメラニン生成過程でのチロジ
ナーゼ活性阻害が必要であるという考え方に基づき、こ
れまで種々の美白成分が提案されてきた。
(Problems to be Solved by the Prior Art and Invention) Generally, when ultraviolet rays from sunlight are applied to the skin, thyroninase activity in the skin causes melanin to be produced and increased remarkably, resulting in blackening of the skin. ing. Therefore, various whitening ingredients have been proposed so far based on the idea that inhibition of tyrosinase activity in the process of melanin production is required to prevent or improve color black.

従来、これら美白成分としては、アスコルビン酸類、
過酸化水素、更にはグルタチオン等の硫黄化合物群等が
知られている。
Conventionally, as these whitening ingredients, ascorbic acids,
Hydrogen peroxide and a group of sulfur compounds such as glutathione are known.

しかし、これらの美白成分は、処方系中における安定
性が悪く、例えば分解による着色・異臭を生じたり、経
皮吸収性の点から効果、効能が不十分であったり、更に
は安全性上問題のある物質を含むなど、未だ十分に満足
すべきものは得られていなかった。
However, these whitening ingredients have poor stability in the formulation system, for example, coloring and off-flavor due to decomposition, insufficient transdermal absorbability, insufficient efficacy, and further safety problems. Satisfactory results such as the inclusion of certain substances have not yet been obtained.

(問題点を解決する手段) そこで本発明者らは、上記の現状に鑑みこれらの問題
を解決すべくチロジナーゼ活性阻害効果という視点から
多くの天然物及び合成化合物について探索検討したとこ
ろ、スチルベンにはチロジナーゼ活性を阻害する効果が
なかったが、その類縁化合物である4−ヒドロキシスチ
ルベンがその効果を有することを発見した。更に研究を
重ねた結果、後記一般式(I)で表わされるポリヒドロ
キシスチルベンが強力なチロジナーゼ活性阻害効果を有
することを突止め、これを化粧料基剤中に一定濃度以上
で含有せしめた時に優れた美白効果を発現することを見
出し、本発明を完成するに至った。
(Means for Solving Problems) Therefore, in view of the above-mentioned situation, the present inventors have searched and examined many natural products and synthetic compounds from the viewpoint of thyrodinase activity inhibitory effect in order to solve these problems. Although there was no effect of inhibiting tyrosinase activity, it was discovered that its related compound, 4-hydroxystilbene, had that effect. As a result of further research, it was found that the polyhydroxystilbene represented by the general formula (I) described later has a strong tyrosinase activity inhibitory effect, and it was excellent when it was contained in a cosmetic base at a certain concentration or more. It has been found that the whitening effect is exhibited and the present invention has been completed.

すなわち本発明は一般式(I) (式中nは0,1,2,3または4の数を、mは0,1,2,3,4また
は5の数を示す) で表わされるポリヒドロキシスチルベンを有効成分とし
て含有することを特徴とする美白化粧料に関する。
That is, the invention has the general formula (I) (Wherein n is the number 0, 1, 2, 3 or 4 and m is the number 0, 1, 2, 3, 4 or 5) is contained as an active ingredient. A featured whitening cosmetic composition.

本発明に適用される前述の一般式(I)で表わされる
ポリヒドロキシスチルベン系化合物は、4位にフェノー
ル性水酸基を有したスチルベン構造をなすことが必須で
ある。この条件が満足されている限りほとんどすべての
スチルベン系化合物が使用可能である。具体例として
は、4−ヒドロキシスチルベン、2,4−ジヒドロキシス
チルベン、3,4−ジヒドロキシスチルベン、4,4′−ジヒ
ドロキシスチルベン、2,4,4′−トリヒドロキシスチル
ベン、3,4,4′−トリヒドロキシスチルベン、2′,4′,
4−トリヒドロキシスチルベン、3′,4,4′−トリヒド
ロキシスチルベン、3′4,5′−トリヒドロキシスチル
ベン、2,3′,4−トリヒドロキシスチルベン、2′,3,4
トリヒドロキシスチルベン、2,2′,4−トリヒドロキシ
スチルベン、2′4,4′,5′−テトラヒドロキシスチル
ベン、2,3′,4,5′−テトラヒドロキシスチルベン、2,
2′,4,4′−テトラヒドロキシスチルベン、3,3′,4,5′
−テトラヒドロキシスチルベン、2′,3,4,4′−テトラ
ヒドロキシスチルベン、3,3′,4,4′−テトラヒドロキ
シスチルベン、3,3′,4,5,5′−ペンタヒドロキシスチ
ルベン、2,2′,4,4′,6′−ペンタヒドロキシスチルベ
ン、2′,3,4,4′,6′−ペンタヒドロキシスチルベン等
が挙げられ、これらの1種または2種以上を混合して用
いるものである。特に2,3′,4,5′−テトラヒドロキシ
スチルベン、3,3′,4,5′−テトラヒドロキシスチルベ
ンが最も効果がある。
It is essential that the polyhydroxystilbene compound represented by the general formula (I) applied to the present invention has a stilbene structure having a phenolic hydroxyl group at the 4-position. As long as this condition is satisfied, almost all stilbene compounds can be used. Specific examples include 4-hydroxystilbene, 2,4-dihydroxystilbene, 3,4-dihydroxystilbene, 4,4'-dihydroxystilbene, 2,4,4'-trihydroxystilbene, 3,4,4'- Trihydroxystilbene, 2 ', 4',
4-trihydroxystilbene, 3 ', 4,4'-trihydroxystilbene, 3'4,5'-trihydroxystilbene, 2,3', 4-trihydroxystilbene, 2 ', 3,4
Trihydroxystilbene, 2,2 ', 4-trihydroxystilbene, 2'4,4', 5'-tetrahydroxystilbene, 2,3 ', 4,5'-tetrahydroxystilbene, 2,
2 ', 4,4'-tetrahydroxystilbene, 3,3', 4,5 '
-Tetrahydroxystilbene, 2 ', 3,4,4'-tetrahydroxystilbene, 3,3', 4,4'-tetrahydroxystilbene, 3,3 ', 4,5,5'-pentahydroxystilbene, 2 , 2 ', 4,4', 6'-pentahydroxystilbene, 2 ', 3,4,4', 6'-pentahydroxystilbene and the like can be mentioned, and one kind or a mixture of two or more kinds thereof is used. It is a thing. In particular, 2,3 ', 4,5'-tetrahydroxystilbene and 3,3', 4,5'-tetrahydroxystilbene are most effective.

本発明に適用されるポリヒドロキシスチルベン系化合
物を合成する方法としては種々あるが、特に効果の高い
2,3′,4,5′−テトラヒドロキシスチルベン、3,3′,4,
5′−テトラヒドロキシスチルベンの合成例を示す。
There are various methods for synthesizing the polyhydroxystilbene compound applied to the present invention, but the effect is particularly high.
2,3 ', 4,5'-tetrahydroxystilbene, 3,3', 4,
An example of the synthesis of 5'-tetrahydroxystilbene is shown below.

合成例1. 2,3′,4,5′−テトラヒドロキシスチルベン 3,5−ジヒドロキシベンジルトリフェニルフォスフォ
ニウム塩と2,4−ジヒドロキシベンズアルデヒドとのWit
tig反応によって合成した。[E.Reimann“Tetrahedron
Letters"47,4051(1970)参照]1 H NMR δ値ppmとカップリングコンスタント(CD3COC
D3) 6.45(J=2.2Hz,C3−H) 6.39(J=2.2,8.5Hz,C5−H) 7.42(J=8.5Hz,C6−H) 6.90(J=16.3Hz,C7−H) 7.35(J=16.3Hz,C8−H) 6.53(J=2.2Hz,C2′,6′−H) 6.25(J=2.2Hz,C4′−H)13 C NMR δ値ppm(CD3COCD3) 117.68(C1),157.32(C2), 104.09(C3),159.52(C4), 108.88(C5),128.68(C6), 124.77(C7),126.70(C8), 142.09(C1′), 105.91(C2′,6′) 159.95(C3′,5′) 102.72(C4′) 合成例2. 3,3′,4,5′−テトラヒドロキシスチルベン 3,5−ジヒドロキシベンジルトリフェニルフォスフォ
ニウム塩と3,4−ジヒドロキシベンズアルデヒドとのWit
tig反応によって合成した。[E.Reimann“Tetrahedron
Letters"47,4051(1970)参照]1 H NMR δ値ppmとカップリングコンスタント(CD3COC
D3) 7.05(J=1.9Hz,C2−H), 6.79(J=8.1Hz,C5−H) 6.81(J=1.9,8.1Hz,C6−H), 6.80(J=16.1Hz,C7−H), 6.91(J=16.1Hz,C8−H), 6.51(J=2.2Hz,C2,6′−H) 6.25(J=2,2Hz,C4′−H)13 C NMR δ値ppm(CD3COCD3) 132.9(C1),116.1(C2), 146.0(C3),146.2(C4), 113.7(C5),119.8(C6), 126.8(C7),129.6(C8), 140.7(C1′), 105.5(C2,6′), 159.5(C3,5′), 102.5(C4′) 上記以外の化合物に関しても同様に該当するフォスフ
ォニウム塩と該当するアルデヒドとのWittig反応によっ
て合成することができる。
Synthesis Example 1. Wit of 2,3 ', 4,5'-tetrahydroxystilbene 3,5-dihydroxybenzyltriphenylphosphonium salt and 2,4-dihydroxybenzaldehyde
It was synthesized by the tig reaction. [E.Reimann “Tetrahedron
Letters "47, 4051 (1970) refer] 1 H NMR δ values ppm and coupling constant (CD 3 COC
D 3) 6.45 (J = 2.2Hz , C 3 -H) 6.39 (J = 2.2,8.5Hz, C 5 -H) 7.42 (J = 8.5Hz, C 6 -H) 6.90 (J = 16.3Hz, C 7 -H) 7.35 (J = 16.3Hz, C 8 -H) 6.53 (J = 2.2Hz, C 2 ', 6'-H) 6.25 (J = 2.2Hz, C4'-H) 13 C NMR δ value ppm ( CD 3 COCD 3 ) 117.68 (C 1 ), 157.32 (C 2 ), 104.09 (C 3 ), 159.52 (C 4 ), 108.88 (C 5 ), 128.68 (C 6 ), 124.77 (C 7 ), 126.70 (C 8 ), 142.09 (C 1 ′), 105.91 (C 2 ′, 6 ′) 159.95 (C 3 ′, 5 ′) 102.72 (C 4 ′) Synthesis example 2, 3, 3 ′, 4,5 ′ -tetrahydroxy Wit of stilbene 3,5-dihydroxybenzyltriphenylphosphonium salt and 3,4-dihydroxybenzaldehyde
It was synthesized by the tig reaction. [E.Reimann “Tetrahedron
Letters "47, 4051 (1970) refer] 1 H NMR δ values ppm and coupling constant (CD 3 COC
D 3) 7.05 (J = 1.9Hz , C2-H), 6.79 (J = 8.1Hz, C 5 -H) 6.81 (J = 1.9,8.1Hz, C 6 -H), 6.80 (J = 16.1Hz, C 7 -H), 6.91 (J = 16.1Hz, C 8 -H), 6.51 (J = 2.2Hz, C 2 ', 6' -H) 6.25 (J = 2,2Hz, C 4 '-H) 13 C NMR δ value ppm (CD 3 COCD 3 ) 132.9 (C 1 ), 116.1 (C 2 ), 146.0 (C 3 ), 146.2 (C 4 ), 113.7 (C 5 ), 119.8 (C 6 ), 126.8 (C 7 ). ), 129.6 (C 8 ), 140.7 (C 1 ′), 105.5 (C 2, 6 ′), 159.5 (C 3, 5 ′), 102.5 (C 4 ′) The same applies to other compounds. Can be synthesized by the Wittig reaction between the phosphonium salt and the corresponding aldehyde.

本発明の美白化粧料では前記のポリヒドロキシスチル
ベンの1種または2種以上を選択して用いることができ
る。その配合量は、化粧料成分全重量中0.00001〜1重
量%、好ましくは0.00005〜0.5重量%である。0.00001
重量%以下では皮膚に対し本発明美白化粧料を塗布して
も経皮吸収量が美白効果を発現する至適量とならず、逆
に1重量%以上の場合は過度のチロジナーゼ活性阻害に
よる不自然な脱色効果を皮膚に与えやすいので避けるべ
きである。
In the whitening cosmetic composition of the present invention, one or more of the above polyhydroxystilbenes can be selected and used. The blending amount thereof is 0.00001 to 1% by weight, preferably 0.00005 to 0.5% by weight, based on the total weight of the cosmetic ingredients. 0.00001
If it is less than 1% by weight, the percutaneous absorption does not reach the optimum amount for exhibiting a whitening effect even if the whitening cosmetic composition of the present invention is applied to the skin, while if it is more than 1% by weight, it is unnatural due to excessive inhibition of tyrosinase activity. It should be avoided as it tends to give the skin a decolorizing effect.

つぎに、ポリヒドロキシスチルベンが、色黒の防止・
改善に効果のあることを実証するため、メラニンの生合
成に関与している酵素チロジナーゼに対する阻害作用に
ついて実験した結果を実験条件を含めて以下に述べる。
Next, polyhydroxystilbene
In order to demonstrate the effect of the improvement, the results of experiments on the inhibitory effect on tyrosinase, an enzyme involved in the biosynthesis of melanin, are described below including the experimental conditions.

酵素チロジナーゼはHarding−Passayマウスメラノー
マから抽出した酵素を使用した。酵素活性はL−ドーパ
を基質としてドーパクロームの生成量を吸収極大475nm
の吸光度で測定するフォトメトリー法に従った。試験物
質ポリヒドロキシスチルベンは0.1Mリン酸緩衝液にそれ
ぞれ所定の濃度に、一定量のノニオン系界面活性剤(終
濃度0.25%)で可溶化したものを作成し、この試験試料
溶液1.8mlにチロジナーゼ酵素溶液0.2mlを添加し、37℃
で10分間インキュベートする。予め37℃でインキュベー
トした5mMのL−ドーパ溶液1.0mlをこの反応混合液に加
え10分間反応させ、ドーパクロームの生成を475nmの吸
光度の増加として分光光度計で経時的に測定した。試料
を添加しないコントロール溶液の吸光度の増分(Ac)
と、試料を添加した反応溶液の吸光度の増分(As)より
阻害率を算出した。
The enzyme tyrosinase used was an enzyme extracted from Harding-Passay mouse melanoma. Enzyme activity absorbs the amount of dopachrome produced using L-dopa as a substrate.
According to the photometry method, the absorbance was measured. The test substance polyhydroxystilbene was prepared by solubilizing 0.1M phosphate buffer solution to a predetermined concentration with a fixed amount of nonionic surfactant (final concentration 0.25%). Add 0.2 ml of enzyme solution, 37 ℃
Incubate for 10 minutes. 1.0 ml of 5 mM L-dopa solution pre-incubated at 37 ° C was added to this reaction mixture and reacted for 10 minutes, and the production of dopachrome was measured with a spectrophotometer as an increase in absorbance at 475 nm with time. Increment in absorbance of control solution without sample (Ac)
Then, the inhibition rate was calculated from the increment (As) of the absorbance of the reaction solution containing the sample.

上述した様に行なわれた実験で得られた、単独物質に
対する値を表−1に示す。
The values for the single substance obtained in the experiment conducted as described above are shown in Table-1.

この結果より、ポリヒドロキシスチルベンはチロジナ
ーゼ活性を阻害し、ドーパクロームの生成を低下させる
ことが実証された。
The results demonstrate that polyhydroxystilbene inhibits tyrosinase activity and reduces dopachrome production.

本発明の美白化粧料に配合されるポリヒドロキシスチ
ルベン系化合物を美白化粧料の基剤に配合する場合に
は、これらを単独、あるいは、その他の還元性皮膚黒化
防止物質と共に用いてもよい。
When the polyhydroxystilbene compound compounded in the whitening cosmetic composition of the present invention is compounded in the base of the whitening cosmetic composition, these may be used alone or together with other reducing skin-blackening preventing substances.

以上、詳述したとおり、本発明はポリヒドロキシスチ
ルベン系化合物を皮膚の色黒を防止,改善する成分とし
て効果的に配合した美白化粧料に関するものであり、従
来知られている各種アスコルビン酸類、過酸化水素,グ
ルタチオン等化合物の美白物質を配合した化粧料に比
べ、日光からの紫外線照射によって生じる皮膚の黒化を
はるかに防ぐことができ、皮膚の色黒やシミ,ソバカス
の防止、美肌効果等の効果が優れていると共に皮膚に対
し何らの弊害もなく安全に用いることができる。
As described above in detail, the present invention relates to a whitening cosmetic in which a polyhydroxystilbene compound is effectively blended as a component for preventing and improving the darkness of the skin. Compared with cosmetics containing whitening substances such as hydrogen oxide and glutathione, it is possible to far prevent the blackening of the skin caused by the irradiation of ultraviolet rays from the sun, the prevention of dark skin, stains and freckles, and the effect of beautiful skin. It has excellent effects and can be safely used without any harmful effect on the skin.

ここで、本発明の美白化粧料を用い色白効果、シミ、
ソバカスの改善効果を検討し、併せて従来の美白化粧料
とを比較した。適用方法としては、色黒、シミ、ソバカ
スに悩む32〜48才の女性30名を選び、これらを無作為に
3群(各10名)に分け、第1群には後記実施例1の美白
化粧水を、第2群には実施例1中の2,3′,4,5′−テト
ラヒドロキシスチルベンを酸化型グルタチオンに置き換
えた美白化粧水を、また第3群には、実施例1中の2,
3′,4,5′−テトラヒドロキシスチルベンを除去(水を
増量)したコントロールの化粧水を、それぞれ1日につ
き朝、昼、晩の3回、3ヶ月間継続して使用してもら
い、色黒、シミ、ソバカスの改善状態を3ヶ月後に報告
させた。
Here, using the whitening cosmetic composition of the present invention, a whitening effect, a stain,
The effect of improving freckles was examined and also compared with conventional whitening cosmetics. As an application method, 30 women aged 32 to 48 who suffer from dark blacks, stains, and freckles were selected, and these were randomly divided into 3 groups (10 people each), and the 1st group had the whitening of Example 1 described later. A lotion, a whitening lotion in which 2,3 ′, 4,5′-tetrahydroxystilbene in Example 1 was replaced with oxidized glutathione in the second group, and a third group in Example 1 was used. of 2,
Have the control lotion from which 3 ', 4,5'-tetrahydroxystilbene was removed (increased the amount of water) be used continuously in the morning, noon and evening 3 times a day for 3 months, The improvement status of black, stains and freckles was reported after 3 months.

その結果を表−2に示す。 The results are shown in Table-2.

表−2に示された結果によれば、本発明品を使用した
第1群における改善効果が比較品を使用した第2群、第
3群に比べて格段に優れていることが実証された。これ
は、本発明に係る美白化粧料に配合されたヒドロキシス
チルベンがチロシナーゼ活性阻害作用およびメラニン色
素脱色作用による美白効果を有効に発揮していることを
示すものである。
The results shown in Table 2 demonstrate that the improvement effect in the first group using the product of the present invention is significantly superior to the second group and the third group using the comparative product. . This shows that the hydroxystilbene contained in the whitening cosmetic composition according to the present invention effectively exhibits the whitening effect by the tyrosinase activity inhibitory action and the melanin pigment decolorizing action.

次に本発明美白化粧料の実施例を示す。配合割合は重
量部である。
Next, examples of the whitening cosmetic composition of the present invention will be shown. The mixing ratio is parts by weight.

実施例1. 美白化粧水 エタノール 10.0 プロピレングリコール 5.0 ポリオキシエチレン(50)水添ヒマシ油 0.5 クエン酸 0.015 クエン酸ナトリウム 0.1 メチルパラベン 0.05 2,3′,4,5′−テトラヒドロキシスチルベン 0.0005 香料 適量 精製水 84.3 実施例2. 美白化粧オイル スクワラン 49.9 ヒマシ油 49.9 3,3′,4,5′−テトラヒドロキシスチルベン 0.001 ブチルヒドロキシトルエン 0.001 香料 適量 実施例4. 美白乳液 油相 ワセリン 1.0 鯨ロウ 1.0 スクワラン 5.0 ホホバ油 1.0 3′,4,5′−トリヒドロキシスチルベン 0.005 ソルビタンモノステアレート 1.0 ポリオキシエチレン(25)モノステアレート 2.0 水相 カルボキシビニルポリマー 0.2 トリエタノールアミン 0.5 プロピレングリコール 5.0 香料・防腐剤 適量 精製水 83.3 実施例5. 美白パック ポリビニルアルコール 20.0 エタノール 20.0 2,3′,4,5′−テトラヒドロキシスチルベン 0.002 グリセリン 5.0 香料 適量 精製水 55.0 実施例6. 固形ファンデーション タルク 25.0 セリサイト 25.0 ナイロンパウダー 3.0 チタンマイカ 3.0 酸化チタン 8.0 酸化鉄 1.5 防腐剤 0.2 シリコーン油 4.0 オレイン酸オクチドデシル 10.0 2,3′,4,5′−テトラヒドロキシスチルベン 0.001 3,4−ジヒドロキシ−3′,5′−ジアセトキシスチルベ
ン 0.01 香料 適量 パール剤 20.0
Example 1. Whitening lotion Ethanol 10.0 Propylene glycol 5.0 Polyoxyethylene (50) Hydrogenated castor oil 0.5 Citric acid 0.015 Sodium citrate 0.1 Methylparaben 0.05 2,3 ', 4,5'-Tetrahydroxystilbene 0.0005 Fragrance Purified water 84.3 Example 2. Whitening Makeup Oil Squalane 49.9 Castor Oil 49.9 3,3 ', 4,5'-Tetrahydroxystilbene 0.001 Butylhydroxytoluene 0.001 Fragrance Suitable amount Example 4. Whitening emulsion Oil phase Vaseline 1.0 Whale wax 1.0 Squalane 5.0 Jojoba oil 1.0 3 ', 4,5'-Trihydroxystilbene 0.005 Sorbitan monostearate 1.0 Polyoxyethylene (25) monostearate 2.0 Aqueous phase Carboxyvinyl polymer 0.2 Triethanolamine 0.5 Propylene glycol 5.0 Perfume / preservative Suitable amount Purified water 83.3 Implementation Example 5. Whitening pack Polyvinyl alcohol 20.0 eta Nole 20.0 2,3 ', 4,5'-Tetrahydroxystilbene 0.002 Glycerin 5.0 Perfume Suitable amount Purified water 55.0 Example 6. Solid foundation talc 25.0 Sericite 25.0 Nylon powder 3.0 Titanium mica 3.0 Titanium oxide 8.0 Iron oxide 1.5 Preservative 0.2 Silicone Oil 4.0 Octidodecyl oleate 10.0 2,3 ', 4,5'-Tetrahydroxystilbene 0.001 3,4-Dihydroxy-3', 5'-diacetoxystilbene 0.01 Fragrance Suitable amount Pearling agent 20.0

Claims (2)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】美白物質として一般式(I) (式中nは0、1、2、3または4の数を、mは0、
1、2、3、4または5の数を示す。) で表されるヒドロキシスチルベンを1種または2種以上
配合することを特徴とする美白化粧料。
1. A general formula (I) as a whitening substance. (Where n is a number 0, 1, 2, 3 or 4 and m is 0,
The numbers 1, 2, 3, 4 or 5 are indicated. ) 1 or 2 or more types of hydroxy stilbene represented by these are contained, The whitening cosmetic characterized by the above-mentioned.
【請求項2】前記ヒドロキシスチルベンの配合量が化粧
料全体に対して0.00001〜1重量%である特許請求の範
囲第1項記載の美白化粧料。
2. The whitening cosmetic composition according to claim 1, wherein the amount of the hydroxystilbene compounded is 0.00001 to 1% by weight based on the entire cosmetic composition.
JP19204087A 1987-07-31 1987-07-31 Whitening cosmetics Expired - Fee Related JP2502318B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP19204087A JP2502318B2 (en) 1987-07-31 1987-07-31 Whitening cosmetics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19204087A JP2502318B2 (en) 1987-07-31 1987-07-31 Whitening cosmetics

Publications (2)

Publication Number Publication Date
JPS6438009A JPS6438009A (en) 1989-02-08
JP2502318B2 true JP2502318B2 (en) 1996-05-29

Family

ID=16284606

Family Applications (1)

Application Number Title Priority Date Filing Date
JP19204087A Expired - Fee Related JP2502318B2 (en) 1987-07-31 1987-07-31 Whitening cosmetics

Country Status (1)

Country Link
JP (1) JP2502318B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170100313A1 (en) * 2010-02-09 2017-04-13 Drexel University Methods of inhibiting, protecting against, or treating uvr-induced skin damage
US11179305B2 (en) 2015-08-10 2021-11-23 Mary Kay Inc. Topical compositions

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2562092B2 (en) * 1992-03-05 1996-12-11 ユシロ化学工業株式会社 Mutagen inhibitor
US6270780B1 (en) * 1997-07-25 2001-08-07 Chesebrough-Pond's Usa Co., Division Of Conopco Cosmetic compositions containing resveratrol
FR2778561B1 (en) * 1998-05-14 2001-04-20 Oreal OPTICAL WHITENERS AS WHITENING AGENTS
FR2787319B1 (en) 1998-12-22 2002-06-14 Oreal USE OF HYDROXYSTILBENES FOR DYEING, READY-TO-USE COMPOSITION CONTAINING THEM AND DYEING PROCESS
FR2789577B1 (en) * 1999-02-17 2002-04-05 Oreal USE OF DERIVATIVES SUBSTITUTED IN 3 OF STILBENE AS DEODORING ACTIVE INGREDIENTS IN COSMETIC COMPOSITIONS
FR2796278B1 (en) * 1999-07-16 2002-05-03 Oreal USE OF AT LEAST ONE HYDROXYSTILBENE AS AN ANTI-GLYCATION AGENT
FR2820975B1 (en) * 2001-02-21 2004-03-12 Oreal COMPOSITION FOR TOPICAL APPLICATION COMPRISING AT LEAST ONE HYDROXYSTILBENE AND AT LEAST ONE POLYOL FOR SOLUBILIZING THE HYDROXYSTILBENE
DE10161253A1 (en) * 2001-12-13 2003-06-26 Dragoco Gerberding Co Ag Use of dihydropinosylvin and its derivatives as inhibitors
EP1575544A1 (en) * 2002-12-18 2005-09-21 L'oreal Use of an alkyl ether of hydroxystilbene for the treatment of dry skin
FR2848844B1 (en) * 2002-12-18 2005-05-06 Oreal USE OF HYDROXYSTILENE ALKYL ETHER FOR THE TREATMENT OF DRY SKINS
KR20130115309A (en) 2010-11-22 2013-10-21 디에스엠 아이피 어셋츠 비.브이. Use of uv-filters to stabilize resveratrol in topical cosmetic compositions
BR112013012586B1 (en) 2010-11-22 2018-02-06 Dsm Ip Assets B.V. USING UV FILTERS TO INCREASE RESVERATROL DERMAL PENETRATION IN TOPICAL COSMETIC COMPOSITIONS
EP2522328A1 (en) 2011-05-09 2012-11-14 DSM IP Assets B.V. Use of resveratrol and ascorbyl-2-glucoside
EP2522329A1 (en) 2011-05-09 2012-11-14 DSM IP Assets B.V. Use of resveratrol and arbutin
EP2522330A1 (en) 2011-05-09 2012-11-14 DSM IP Assets B.V. Use of resveratrol and an edelweiss extract
EP2522335A1 (en) 2011-05-09 2012-11-14 DSM IP Assets B.V. Use of resveratrol and sodium-ascorbyl-phophate
EP2522331A1 (en) 2011-05-09 2012-11-14 DSM IP Assets B.V. Use of resveratrol and niacinamide
EP2522332A1 (en) 2011-05-09 2012-11-14 DSM IP Assets B.V. Use of resveratrol and magnesium-ascorbyl-phosphate
US9060945B2 (en) 2012-01-09 2015-06-23 Dsm Ip Assets B.V. Use of danielone and derivatives thereof in skin care
JP5918168B2 (en) * 2012-04-27 2016-05-18 富士フイルム株式会社 β-Glucocerebrosidase activity enhancer
KR101480600B1 (en) * 2013-01-22 2015-01-08 경북대학교 산학협력단 A use for skin whitening of resveratrol derivatives
WO2015156328A1 (en) 2014-04-09 2015-10-15 江崎グリコ株式会社 Skin aging inhibitor and concentrate of resveratrol 3-o-α-glucoside
FR3071731B1 (en) 2017-09-29 2020-06-19 L'oreal RESORCINOL DERIVATIVES FOR THEIR COSMETIC USE
CN111281812A (en) * 2018-12-10 2020-06-16 深圳市前海博斐生物科技有限公司 Application of cajanin

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170100313A1 (en) * 2010-02-09 2017-04-13 Drexel University Methods of inhibiting, protecting against, or treating uvr-induced skin damage
US11179305B2 (en) 2015-08-10 2021-11-23 Mary Kay Inc. Topical compositions

Also Published As

Publication number Publication date
JPS6438009A (en) 1989-02-08

Similar Documents

Publication Publication Date Title
JP2502318B2 (en) Whitening cosmetics
JP2565513B2 (en) Topical drug for suppressing melanin production
JPH022848B2 (en)
JPH04342519A (en) Skin cosmetic
JPH03236322A (en) Skin drug for external use
JP2903412B2 (en) Cosmetics
JPH10330219A (en) Melanogenesis inhibitor and skin whitening agent
JP2549127B2 (en) Topical drug for suppressing melanin production
JPH05271046A (en) Dermal medicine for external use
JP3460100B2 (en) Whitening agent
JPH10279428A (en) Cosmetic
JPH06227959A (en) Melanin formation inhibitor and skin cosmetic
JP2003267854A (en) Bleaching cosmetic
JP3480954B2 (en) External preparation for skin
JPH10182404A (en) Preparation for external use for skin
JP2565516B2 (en) Topical skin
JP3119622B2 (en) Cosmetics
JP2002370962A (en) Bleaching preparation and cosmetic for preventing and improving aging of skin
JPH10120546A (en) Skin whitening preparation for external use
JPH05294819A (en) Beautifying cosmetic
JP3026616B2 (en) Whitening cosmetics
JPH0118044B2 (en)
JPH01149706A (en) Skin-beautifying cosmetic
JP2005272444A (en) External preparation for skin
JP2004175688A (en) Bleaching agent and cosmetic

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees